Quick Dispatch:
Your summit study tirzepatide Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your summit study tirzepatide Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity ships.
Need Help?
Questions about summit study tirzepatide Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for summit study tirzepatide Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity in your area.
01200-X/asset/429e6fd1-61d1-402a-91a5-b2ec86b1b878/main.assets/gr2_lrg.jpg)
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
20.45
Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity
22.94
SURMOUNT-3 study design This is a phase 3, multicenter, randomized,
27.00
Has Tirzepatide Scaled the HFpEF/Obesity SUMMIT?
21.90
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists
20.29
💊 New research in obesity & heart failure The SUMMIT study looked at tirzepatide, a once-weekly injection, in people with both obesity and heart failure with preserved ejection fraction (HFpEF). Over 52
28.51
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM 🥸The SUMMIT trial
27.91
